<DOC>
	<DOCNO>NCT01975350</DOCNO>
	<brief_summary>There might additional benefit clinical outcome adjunctive colistimethate sodium inhalation therapy multidrug resistant Gram-negative ventilator-associated pneumonia .</brief_summary>
	<brief_title>Efficacy Study Colistimethate Sodium Inhalation Patients With Ventilator-associated Pneumonia</brief_title>
	<detailed_description>Besides , early antibiotic intervention might benefit patient ventilator-associated tracheobronchitis low airway colonization multidrug resistant Gram-negative bacteria .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Respiratory Aspiration</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Colistin</mesh_term>
	<criteria>1. age ≥ 20 year old 2. medical ICU patient invasive ventilator use ≥ 48 hour 3. multidrug resistant Gramnegative bacteria obtain low respiratory tract 1. pregnancy 2. concurrent use antimicrobial agent active isolated multidrug resistant Gramnegative bacteria ( defined resistant carbapenem , fluoroquinolone , antipseudomonas betalactams ) , tigecycline , aminoglycosides , sulbactam 3. patient refuse receive inhale therapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Colistimethate sodium inhalation</keyword>
</DOC>